Skip to main content
News

HAPPE Spine Announces New Addition to Board of Directors

By May 2, 2025No Comments

Grand Rapids, Mich., May 2, 2023HAPPE Spine, an emerging leader in the development of next generation orthopedic and spinal implants enabled by the HAPPE™ material platform, announces a new addition to its Board of Directors.

Jason Topolosky

Jason Topolosky brings more than twenty years of experience in business development and strategy in orthopedic devices. He currently serves as Chief Business Development Officer for OsteoCentric Technologies, as well as leadership and advising roles with other medical device startups and investment funds. Mr. Topolosky previously served in various leadership positions in business development and strategy at Stryker Corp. for nearly twenty years.

Mr. Topolosky said, “I am excited to join the HAPPE Spine Board at an exciting time in the company’s growth and look forward to leveraging my past experience as a medical device strategist and M&A executive to provide advice as we elevate spine care and explore new areas of growth for the HAPPE platform.”

The remaining seats on the board are held by Matt Ahearn (Director, Cultivate MD Capital Funds), Steven M. Foster (CEO, Tenon Medical), Brian McCollum (COO, Health Concept Partners), and Dr. Ryan K. Roeder (Founder, CTO, and Interim CEO, HAPPE Spine).

HAPPE Spine LLC is a medical device development company that designs and manufactures innovative orthopedic and spinal implants utilizing the proprietary Hydroxyapatite Porous Polyetheretherketone (HAPPE®) material platform. The HAPPE platform creates bone-integrating implants that look and act like a biologic. HAPPE has commercialized INTEGRATE®-C cervical interbody spinal fusion system for clinical and market validation of the HAPPE platform. The HAPPE material platform overcomes the limitations of titanium and PEEK by mimicking key aspects of the structure and composition of bone to work synergistically with biology to improve healing. The HAPPE INTEGRATE®-C interbody fusion system thus offers allograft-like qualities in a synthetic implant that may improve clinical outcomes in interbody spinal fusion by overcoming the problems of pseudoarthrosis, subsidence and imaging artifacts that limit current PEEK and titanium implants.

Learn more about HAPPE Spine, the HAPPE® material platform at happeortho.com.